Dexlansoprazole Capsule, Delayed Release Pellets
Product Images NDC 0378-2085

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 0378-2085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dexlansoprazole Structural Formula (Image 01)

Dexlansoprazole Structural Formula (Image 01)
Chemical structure of dexlansoprazole showing its molecular framework including the indole, sulfinyl, and pyridine moieties along with a trifluoroethoxy side group and water of hydration (1 1/2 H2O).*
FDA Label Image

Figure 1: Mean Plasma Dexlansoprazole Concentration – Time Profile Following Oral Administration Of 30 Or 60 mg Dexlansoprazole Once Daily For 5 Days In Healthy Adult Subjects (Image 02)

Figure 1: Mean Plasma Dexlansoprazole Concentration – Time Profile Following Oral Administration Of 30 Or 60 mg Dexlansoprazole Once Daily For 5 Days In Healthy Adult Subjects (Image 02)
A line graph depicting plasma concentration (ng/mL) over time (hours) for Dexlansoprazole capsules delayed release pellets at 30 mg and 60 mg strengths. The graph shows two curves indicating plasma levels peaking and then declining over a 24-hour period.*
FDA Label Image

Dexlansoprazole Delayed-release Capsules 30 mg Bottle Label (Image 03)

Dexlansoprazole Delayed-release Capsules 30 mg Bottle Label (Image 03)
Dexlansoprazole 30 mg delayed-release capsules packaging label by Mylan Pharmaceuticals Inc. The label includes NDC 0378-2085-93, a barcode, dosing and storage instructions, and a 30-capsule count indication. It notes the product is for prescription use only and provides handling precautions such as storing at 20° to 25°C and keeping out of reach of children.*
FDA Label Image

Dexlansoprazole Delayed-release Capsules 60 mg Bottle Label (Image 04)

Dexlansoprazole Delayed-release Capsules 60 mg Bottle Label (Image 04)
Label for Dexlansoprazole delayed-release capsules, 60 mg strength, containing 30 capsules per container. The label shows the product as manufactured for Mylan Pharmaceuticals Inc., with dosing and storage instructions, including a note to dispense the accompanying medication guide. The label also includes an NDC code, barcode, and space for lot, expiration, serial, and global trade item numbers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.